Skip to content

The effect of FiO2 modulation using ORI on atelectasis after general anesthesia in children: a randomized controlled trial

The effect of FiO2 modulation using ORI on atelectasis after general anesthesia in children: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007418
Enrollment
146
Registered
2022-06-20
Start date
2022-09-28
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : After anesthesia induction, FiO2 is applied differently during surgery according to the assigned group, *The FiO2 supplied according to the assigned group is as follows. -Control

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pediatric patients under 6 years of age undergoing surgery (non-cardiac surgery) under general anesthesia

Exclusion criteria

Exclusion criteria: Premature infants, a history of previous chest surgery, patients with confirmed upper or lower respiratory tract infections, airway malformations, lung disease, Preoperative chest X-ray abnormal findings (eg atelectasis, pneumonia, pneumothorax, pleural effusion, etc.) airway manipulation surgery

Design outcomes

Primary

MeasureTime frame
comparison of the incidence of atelectasis after anesthesia

Secondary

MeasureTime frame
Comparison of incidence of hypoxia during surgery (SpO2 < 92%);Time-weighted average FiO2

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Inha University Hospital

kimdoyeon31@gmail.com+82-32-890-3948

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026